Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats
- Supplementary File 1:
PDF-Document (PDF, 168 KiB)
Lin, C.-F.; Su, C.-J.; Liu, J.-H.; Chen, S.-T.; Huang, H.-L.; Pan, S.-L. Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats. J. Clin. Med. 2019, 8, 659. https://doi.org/10.3390/jcm8050659
Lin C-F, Su C-J, Liu J-H, Chen S-T, Huang H-L, Pan S-L. Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats. Journal of Clinical Medicine. 2019; 8(5):659. https://doi.org/10.3390/jcm8050659
Chicago/Turabian StyleLin, Chao-Feng, Chih-Jou Su, Jia-Hong Liu, Shui-Tien Chen, Han-Li Huang, and Shiow-Lin Pan. 2019. "Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats" Journal of Clinical Medicine 8, no. 5: 659. https://doi.org/10.3390/jcm8050659

